US Stocks
/
Ernexa Therapeutics Inc. Share Price

Ernexa Therapeutics Inc. Share Price

NASDAQ: ERNA | Micro Cap
$4.41
+$0.12 (2.80%) Last updated on 07 Aug, 2026 | 19:12 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ernexa Therapeutics Inc. Stock Performance

Open
$4.41
Prev. Close
$4.29
Circuit Range
N/A
Day Range
$4.41 - $4.41
Year Range
$0.14 - $15.75
Volume
200
Average Traded
$4.41

Ernexa Therapeutics Inc. Share Price Today

As of 9 August 2026, Ernexa Therapeutics Inc.'s share price is $4.41. The stock opened at $4.41, compared to its previous close of $4.29. During today's trading session, Ernexa Therapeutics Inc.'s share price traded between $4.41 and $4.41, with an average price of $4.41. Over the past 52 weeks, the stock has recorded a high of $15.75 and a low of $0.14. In terms of performance, Ernexa Therapeutics Inc.'s share price has risen by 1405.12% over the last six months and is up 215.00% on a year-on-year basis.

Ernexa Therapeutics Inc. Share Price Chart

$4.41$4.41
L
Show Current Price
H

Ernexa Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$27.81M
PE Ratio (TTM)
-1.97
Dividend Yield
N/A
EPS (TTM)
$-2.24
Revenue (TTM)
$582000.00
Return On Equity (TTM)
-586.59%
Profit Margin
-2419.93%
Debt to Equity
1.30
Quarterly Earnings Growth YoY
N/A

Ernexa Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024
Revenue$47000.00$47000.00$487000.00
Net Profit-$6.65M-$5.53M-$26.60M
Net Profit Margin-14142.55%-11763.83%-5462.83%
Income ChangeN/A16.82%-381.17%

Ernexa Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2024
Revenue$582000.00
Net Profit-$44.54M
Net Profit Margin-7652.75%
Income ChangeN/A

About Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Ernexa Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$3.42
$4.41
+29.71%
Jul 2026
$6.65
$3.40
-49.63%
Jun 2026
$9.44
$6.75
-35.84%
May 2026
$0.15
$10.52
+7,155.17%
Apr 2026
$0.21
$0.14
-27.86%
Mar 2026
$0.29
$0.20
-31.40%
Feb 2026
$1.25
$0.29
-75.98%
Jan 2026
$1.16
$1.22
+0.00%
Dec 2025
$1.28
$1.22
-9.63%
Nov 2025
$1.86
$1.35
-27.81%
Oct 2025
$1.25
$1.87
+59.15%
Sep 2025
$1.40
$1.18
-16.07%

ERNA Share Price FAQs

What is Ernexa Therapeutics Inc. share price today?

chevron-up
Ernexa Therapeutics Inc. share price today is $4.41 as on August 7, 2026 at 7:12 pm IST.

What is the 52 week high and 52 week low of Ernexa Therapeutics Inc. stock?

chevron-up
The 52 week high of Ernexa Therapeutics Inc. stock is $15.75, while the 52 week low is $0.14 as of 7 Aug '26.

What is ERNA's market capitalisation today?

chevron-up
ERNA market capitalisation is $27.81M as of August 9, 2026, at 3:12 pm IST.

What is ERNA's net income for the last quarter?

chevron-up
ERNA's net income for the last quarter is -0.03B USD.

What is the 5 year returns of ERNA?

chevron-up
The 5 year returns of ERNA is -99.88% as on 7 Aug '26.

What is the high & low stock price of ERNA today?

chevron-up
ERNA stock price hit a high of $4.41 and low of $4.41 as of 7 Aug '26.

Can I buy ERNA shares in India?

chevron-up
Yes. You can buy ERNA in India by opening an international trading account.